Jonathan Johnson
Overview
Explore the profile of Jonathan Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hilscher M, Johnson J
Semin Liver Dis
. 2025 Mar;
PMID: 40081822
Fontan associated liver disease (FALD) occurs in all patients who have undergone Fontan palliative repair for functional single ventricle congenital heart defects. While liver fibrosis is universal in patients who...
2.
Lv L, Rajpura J, Liu M, Strum M, Chastek B, Johnson J, et al.
Am J Prev Cardiol
. 2025 Mar;
21:100950.
PMID: 40060171
Background: Systemic inflammation (SI) is a risk factor for atherosclerotic cardiovascular disease (ASCVD) and is most commonly assessed by measuring levels of high-sensitivity C-reactive protein (hsCRP). Objective: This study aimed...
3.
Andersen C, Ayoola G, Johnson Jr A, Johnson J, Kelso M, Serena T, et al.
Adv Skin Wound Care
. 2024 Jul;
37(8):399-403.
PMID: 39037092
No abstract available.
4.
Doh K, Bishop Z, Gillings T, Johnson J, Boy A, Waris R, et al.
Front Public Health
. 2024 Apr;
12:1352400.
PMID: 38577291
Background: In the United States, 33% of households with children contain firearms, however only one-third reportedly store firearms securely. It's estimated that 31% of unintentional firearm injury deaths can be...
5.
Johnson J, Johnson Jr A, Andersen C, Kelso M, Oropallo A, Serena T
J Racial Ethn Health Disparities
. 2023 Apr;
11(2):1045-1055.
PMID: 37039975
Underrepresentation of diverse skin tones in medical education and providers' implicit racial bias drives inequities in wound care, such as disproportionally poor outcomes for Black patients. Diagnostic indicators (e.g., erythema)...
6.
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl
Derington C, Bress A, Herrick J, Fan W, Wong N, Andrade K, et al.
Am J Prev Cardiol
. 2022 May;
10:100345.
PMID: 35574517
Objective: To explore the population health impact of treating all US adults eligible for the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT) with icosapent ethyl (IPE), we estimated...
7.
Weintraub W, Bhatt D, Zhang Z, Dolman S, Boden W, Bress A, et al.
JAMA Netw Open
. 2022 Feb;
5(2):e2148172.
PMID: 35157055
Importance: The Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial (REDUCE-IT) demonstrated the efficacy of icosapent ethyl (IPE) for high-risk patients with hypertriglyceridemia and known cardiovascular disease or diabetes and...
8.
Chowdhury D, Fremed M, Dean P, Glickstein J, Robinson J, Rellosa N, et al.
Sports Health
. 2021 Aug;
14(4):460-465.
PMID: 34427496
Context: Sedentary behavior and inability to participate in organized physical activity has negatively affected the physical and mental health of children and adolescents; however, cardiac injury and associated risk for...
9.
Adewale O, Egbeyemi K, Onwuelu J, Potts-Johnson S, Anadozie S, Fadaka A, et al.
Heliyon
. 2020 Nov;
6(11):e05501.
PMID: 33251363
The use of plant and plant products in the synthesis of silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs) is made possible because of the natural inherent phytochemicals responsible for the...
10.
Kirk R, Dipchand A, Davies R, Miera O, Chapman G, Conway J, et al.
J Heart Lung Transplant
. 2020 Feb;
39(4):331-341.
PMID: 32088108
The number of potential pediatric heart transplant recipients continues to exceed the number of donors, and consequently the waitlist mortality remains significant. Despite this, around 40% of all donated organs...